Giles, RachelMaskens, DeborahBrick, RobertMartinez, RobinPacker, MalcolmHeng, DanielLarkin, JamesBex, AlexJewett, MichaelJonasch, EricMacLennan, Sara J.2022-03-222022-03-222022Giles, R, Maskens, D, Brick, R, Martinez, R, Packer, M, Heng, D, Larkin, J, Bex, A, Jewett, M, Jonasch, E & MacLennan, S J 2022, 'Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas : Results from a Global Patient Survey in 43 Countries', European Urology Open Science, vol. 37, pp. 3-6. https://doi.org/10.1016/j.euros.2021.12.0032666-1683ORCID: /0000-0003-1405-6964/work/110275588https://hdl.handle.net/2164/18279Funding/Support and role of the sponsor: This project was funded by equal unrestricted grants from Bristol-Myers Squibb, Ipsen Pharma, Novartis, and Pfizer according to the IKCC code of conduct governing corporate funding (ikcc.org). The sponsors were not involved in the design or analysis of the survey or approval of the final manuscript.4420291engSDG 3 - Good Health and Well-beingkidney cancerclinical trialspsychosocial supportshared decision-makingpatient-reported experienceR MedicineRPatient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas : Results from a Global Patient Survey in 43 CountriesJournal article10.1016/j.euros.2021.12.00337